Combinedn spinal-epidural analgesia during labour.
Conditions
Interventions
Trade Name: Prostigmine
Pharmaceutical Form: Injection*
Other descriptive name: NEOSTIGMINE METHYLSULFATE
Concentration unit: mg/ml milligram(s)/millilitre
Concentration type: equal
Concentration numb
Sponsors
University Hospitals Leuven
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASA I or II nullipare singleton pregnancy > 37 weeks gestational stage Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: ASA III or IV no episiotomy allergy to local anesthetics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Does the epidural administration of clonidine and neostigmine improves analgesia after episiotomy.;Secondary Objective: What is de incidence of advers events such as: nausea, vomiting, post dural punciton headache, pruritus, sedation, maternal hypotension and bradycardia.;Primary end point(s): Does the epidural administration of neostigmine and clonidine improves analgesia after episiotomy. Does the patient need less NSAID's and paracetamol after epidurale administration of neostigmine and clonidine. | — |
Countries
Belgium
Outcome results
None listed